中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
—— |
ethyl 2,4-dimethyl-5-[[2-(pyridine-2-carbonyl)hydrazinyl]methylidene]pyrrole-3-carboxylate |
—— |
C16H18N4O3 |
|
—— |
(E)-N-[4-(cyanomethyl)phenyl]-3-(4-fluorophenyl)prop-2-enamide |
—— |
C17H13FN2O |
|
—— |
(E)-N-[4-(cyanomethyl)phenyl]-3-phenylprop-2-enamide |
—— |
C17H14N2O |
|
—— |
ethyl 3-[methyl-[(3S)-3,4,4-trimethylpentanoyl]amino]propanoate |
—— |
C14H27NO3 |
|
—— |
ethyl (3S)-1-[[4-(2-chlorophenyl)-5-oxotetrazol-1-yl]methyl]piperidin-1-ium-3-carboxylate |
—— |
C16H21ClN5O3+ |
|
—— |
(E)-N-[2-(tert-butylamino)-2-oxoethyl]-3-(2,5-dimethoxyphenyl)-N-methylprop-2-enamide |
—— |
C18H26N2O4 |
|
—— |
ethyl (3R)-1-[(5-oxo-4-phenyltetrazol-1-yl)methyl]piperidine-3-carboxylate |
—— |
C16H21N5O3 |
|
—— |
ethyl (2S)-2-[(4-cyanobenzoyl)amino]-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)acetate |
—— |
C23H22N4O3 |
|
—— |
ethyl (3S)-1-[[4-(2-chlorophenyl)-5-oxotetrazol-1-yl]methyl]piperidine-3-carboxylate |
—— |
C16H20ClN5O3 |
|
—— |
ethyl 3-[methyl-[(3R)-3,4,4-trimethylpentanoyl]amino]propanoate |
—— |
C14H27NO3 |
|
—— |
ethyl (3R)-1-[(3,5-dimethyl-4-morpholin-4-ylsulfonylpyrazol-1-yl)methyl]piperidin-1-ium-3-carboxylate |
—— |
C18H31N4O5S+ |
|
—— |
ethyl (2R)-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)-2-[[(E)-3-(3-fluorophenyl)prop-2-enoyl]amino]acetate |
—— |
C24H24FN3O3 |
|
—— |
ethyl (2R)-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)-2-[[2-(2-methylphenoxy)acetyl]amino]acetate |
—— |
C24H27N3O4 |
|
—— |
ethyl (2R)-2-[(3,5-difluorobenzoyl)amino]-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)acetate |
—— |
C22H21F2N3O3 |
|
—— |
ethyl (3S)-1-[[4-(diethylsulfamoyl)-3,5-dimethylpyrazol-1-yl]methyl]piperidine-3-carboxylate |
—— |
C18H32N4O4S |
|
—— |
ethyl (2R)-2-[(4-cyanobenzoyl)amino]-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)acetate |
—— |
C23H22N4O3 |
|
—— |
(E)-3-(2-methoxy-5-methylphenyl)-N-(3-morpholin-4-ylsulfonylphenyl)prop-2-enamide |
—— |
C21H24N2O5S |
|
—— |
ethyl (2R)-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)-2-[[2-(2-fluorophenyl)acetyl]amino]acetate |
—— |
C23H24FN3O3 |
|
—— |
ethyl (2R)-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)-2-[(3-methoxybenzoyl)amino]acetate |
—— |
C23H25N3O4 |
|
—— |
ethyl (2R)-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)-2-[[(E)-3-phenylprop-2-enoyl]amino]acetate |
—— |
C24H25N3O3 |
|
—— |
ethyl (3S)-1-[[4-cyclopropyl-5-sulfanylidene-3-(thiophen-2-ylmethyl)-1,2,4-triazol-1-yl]methyl]piperidine-3-carboxylate |
—— |
C19H26N4O2S2 |
|
—— |
ethyl 2-[cyclopropyl-[(3S)-3,4,4-trimethylpentanoyl]amino]acetate |
—— |
C15H27NO3 |
|
—— |
ethyl (2R)-2-[(4-chlorobenzoyl)amino]-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)acetate |
—— |
C22H22ClN3O3 |
|
—— |
(E)-N-[(S)-(4-ethylphenyl)-thiophen-2-ylmethyl]-3-(furan-2-yl)prop-2-enamide |
—— |
C20H19NO2S |
|
—— |
(E)-N-(2-adamantyl)-3-(2-methoxy-5-methylphenyl)prop-2-enamide |
—— |
C21H27NO2 |
|
—— |
(E)-N-[2-(2-amino-2-oxoethyl)sulfanylphenyl]-3-(3-nitrophenyl)prop-2-enamide |
—— |
C17H15N3O4S |
|
—— |
ethyl (3R)-1-[[3,5-dimethyl-4-(4-methylpiperidin-1-yl)sulfonylpyrazol-1-yl]methyl]piperidine-3-carboxylate |
—— |
C20H34N4O4S |
|
—— |
ethyl (3R)-1-[[4-(2-chlorophenyl)-5-oxotetrazol-1-yl]methyl]piperidin-1-ium-3-carboxylate |
—— |
C16H21ClN5O3+ |
|
—— |
ethyl (3R)-1-[(2-hydroxy-3-methoxycarbonylnaphthalen-1-yl)methyl]piperidine-3-carboxylate |
—— |
C21H25NO5 |
|
—— |
ethyl (2S)-2-(3,5-dimethyl-1-phenylpyrazol-4-yl)-2-[[2-(3-methylphenoxy)acetyl]amino]acetate |
—— |
C24H27N3O4 |
|
—— |
ethyl (3R)-1-[[5-(methylamino)-2-sulfanylidene-1,3,4-thiadiazol-3-yl]methyl]piperidine-3-carboxylate |
—— |
C12H20N4O2S2 |
|
—— |
ethyl (3R)-1-[(4-cyclopropyl-3-pyridin-4-yl-5-sulfanylidene-1,2,4-triazol-1-yl)methyl]piperidin-1-ium-3-carboxylate |
—— |
C19H26N5O2S+ |
|
—— |
ethyl (3R)-1-[(5-oxo-4-thiophen-2-yltetrazol-1-yl)methyl]piperidin-1-ium-3-carboxylate |
—— |
C14H20N5O3S+ |
|
—— |
ethyl (3S)-1-[[4-cyclopropyl-5-sulfanylidene-3-(thiophen-2-ylmethyl)-1,2,4-triazol-1-yl]methyl]piperidin-1-ium-3-carboxylate |
—— |
C19H27N4O2S2+ |
|
—— |
(E)-3-[2-(difluoromethoxy)-3-methoxyphenyl]-N-(4-fluoro-2-methylphenyl)prop-2-enamide |
—— |
C18H16F3NO3 |
|
—— |
ethyl (3R)-1-[[5-[(3S)-1,1-dioxothiolan-3-yl]-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]piperidin-1-ium-3-carboxylate |
—— |
C15H24N3O5S2+ |
|
—— |
ethyl (3R)-1-[(2-oxo-5-pyrrolidin-1-ylsulfonylpyridin-1-yl)methyl]piperidine-3-carboxylate |
—— |
C18H27N3O5S |
|
—— |
ethyl (3S)-1-[(2-hydroxy-3-methoxycarbonylnaphthalen-1-yl)methyl]piperidine-3-carboxylate |
—— |
C21H25NO5 |
|
—— |
(E)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-(6-nitro-1,3-benzodioxol-5-yl)prop-2-enamide |
—— |
C14H12N4O5S |
|
—— |
(E)-N-(3,5-dimethoxyphenyl)-3-(6-nitro-1,3-benzodioxol-5-yl)prop-2-enamide |
—— |
C18H16N2O7 |
|
—— |
ethyl (3S)-1-[(6-chloro-2-oxo-1,3-benzoxazol-3-yl)methyl]piperidin-1-ium-3-carboxylate |
—— |
C16H20ClN2O4+ |
|
—— |
ethyl (3R)-1-[[3-(3-amino-3-oxopropyl)-4-ethyl-5-sulfanylidene-1,2,4-triazol-1-yl]methyl]piperidine-3-carboxylate |
—— |
C16H27N5O3S |
|
—— |
(E)-1-(1-methyl-3,4-dihydro-2H-[1,4]diazepino[2,3-b]quinoxalin-5-yl)-3-thiophen-2-ylprop-2-en-1-one |
—— |
C19H18N4OS |
|
—— |
(E)-3-(2-chloro-6-fluorophenyl)-N-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]prop-2-enamide |
—— |
C22H20ClFN4O |
|
—— |
(E)-3-[2-(difluoromethoxy)-3-methoxyphenyl]-N-[(4-methoxyphenyl)methyl]prop-2-enamide |
—— |
C19H19F2NO4 |
|
—— |
ethyl (2S)-1-(4-cyano-2,5-dimethylpyrazol-3-yl)pyrrolidine-2-carboxylate |
—— |
C13H18N4O2 |
|
—— |
(E)-3-(6-methoxynaphthalen-2-yl)-N-[(2-methoxyphenyl)methyl]prop-2-enamide |
—— |
C22H21NO3 |
|
—— |
(E)-3-(2-methoxy-5-methylphenyl)-N-(5-prop-2-enylsulfanyl-1,3,4-thiadiazol-2-yl)prop-2-enamide |
—— |
C16H17N3O2S2 |
|
—— |
(E)-N-[(4-fluorophenyl)methyl]-3-(6-methoxynaphthalen-2-yl)prop-2-enamide |
—— |
C21H18FNO2 |
|
—— |
ethyl (2R)-2-amino-6-(3-methoxypropylsulfanyl)-2-methylhexanoate |
—— |
C13H27NO3S |
|